| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8756446 | Auris Nasus Larynx | 2009 | 6 Pages |
Abstract
In the treatment of CCR for advanced SCCHN, the survival rate of the patients with resectable tumors was excellent and significantly greater compared with the patients with unresectable tumors. T1 to T3 disease in patients with advanced resectable SCCHN is a good predictor of organ preservation. CCR may improve not only primary organ preservation (local control) but also survival in patients with poorly differentiated tumors.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Takahide Taguchi, Mamoru Tsukuda, Yasukazu Mikami, Hideki Matsuda, Yuji Tanigaki, Choichi Horiuchi, Goshi Nishimura, Jun-ichi Nagao,